PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
19.14%
Similar revenue growth to VET's 21.14%. Walter Schloss would investigate if similar growth reflects similar quality.
0.40%
Cost growth less than half of VET's 3.68%. David Dodd would verify if cost advantage is structural.
34.16%
Gross profit growth 1.25-1.5x VET's 26.91%. Bruce Berkowitz would examine sustainability.
12.61%
Margin expansion exceeding 1.5x VET's 4.77%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
-50.74%
Both companies reducing G&A. Martin Whitman would check industry cost trends.
No Data
No Data available this quarter, please select a different quarter.
14.37%
Other expenses growth less than half of VET's 30.28%. David Dodd would verify if advantage is sustainable.
5.25%
Operating expenses growth 1.1-1.25x VET's 4.66%. Bill Ackman would demand justification.
3.15%
Total costs growth 50-75% of VET's 4.25%. Bruce Berkowitz would examine efficiency.
4.20%
Interest expense growth less than half of VET's 22.24%. David Dodd would verify sustainability.
5.16%
D&A growth less than half of VET's 15.22%. David Dodd would verify if efficiency is sustainable.
726.71%
EBITDA growth exceeding 1.5x VET's 34.72%. David Dodd would verify competitive advantages.
17.49%
EBITDA margin growth exceeding 1.5x VET's 11.21%. David Dodd would verify competitive advantages.
163.86%
Operating income growth exceeding 1.5x VET's 45.42%. David Dodd would verify competitive advantages.
121.47%
Operating margin growth exceeding 1.5x VET's 20.05%. David Dodd would verify competitive advantages.
87.18%
Other expenses growth 50-75% of VET's 125.37%. Bruce Berkowitz would examine cost efficiency.
78.21%
Pre-tax income growth below 50% of VET's 190.97%. Michael Burry would check for structural issues.
49.58%
Pre-tax margin growth below 50% of VET's 140.20%. Michael Burry would check for structural issues.
-131.09%
Tax expense reduction while VET shows 181.23% growth. Joel Greenblatt would examine advantage.
125.64%
Net income growth 50-75% of VET's 199.45%. Martin Whitman would scrutinize operations.
89.40%
Net margin growth 50-75% of VET's 147.20%. Martin Whitman would scrutinize operations.
126.42%
EPS growth 50-75% of VET's 200.00%. Martin Whitman would scrutinize operations.
124.53%
Diluted EPS growth 50-75% of VET's 196.67%. Martin Whitman would scrutinize operations.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.